Researchers at Galenea Corp. will share a five-year, $3 million grant from the National Institute of Mental Health (NIMH) with Kevin Spencer of the VA Boston Healthcare System and Harvard Medical School to develop new biomarkers to measure the effectiveness of drugs aimed at schizophrenia.
If you can’t sign in to your HMS account, try using your existing HarvardKey password for your HMS account. If using your HarvardKey password for your HMS account doesn’t work, reset the password for your HarvardKey account, then use your HarvardKey password to sign in to both accounts.
